Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $0.0090 USD
Change Today +0.0002 / 2.27%
Volume 215.4K
EAPH On Other Exchanges
Symbol
Exchange
OTC US
As of 2:55 PM 09/2/15 All times are local (Market data is delayed by at least 15 minutes).

easton pharmaceuticals inc (EAPH) Snapshot

Open
$0.0088
Previous Close
$0.0088
Day High
$0.0091
Day Low
$0.0085
52 Week High
01/28/15 - $0.04
52 Week Low
08/17/15 - $0.0056
Market Cap
1.0M
Average Volume 10 Days
1.5M
EPS TTM
--
Shares Outstanding
115.5M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for EASTON PHARMACEUTICALS INC (EAPH)

Related News

No related news articles were found.

easton pharmaceuticals inc (EAPH) Related Businessweek News

No Related Businessweek News Found

easton pharmaceuticals inc (EAPH) Details

Easton Pharmaceuticals Inc., a specialty pharmaceutical company, designs, develops, and markets various topically delivered drugs and therapeutic health care products. Its products include Nauseasol, a motion sickness gel; Skin Renou HA, an anti-aging wrinkle cream using hyaluronic acid, which keeps the skin smooth; Kenestrin Gel used for arthritis, knees, elbows, shoulders, wrist, and back pain; Viorra, a hormone free, non-toxic, and topical gel that improves sexual functioning of women; and female sexual arousal disorder drug. The company is also developing XILIVE, an early stage cancer drug. In addition, it is involved in the medical marijuana business. The company was formerly known as LAM Industries, Inc. and changed its name to Easton Pharmaceuticals Inc. in March 2010. Easton Pharmaceuticals Inc. was founded in 1997 and is based in Toronto, Canada.

easton pharmaceuticals inc (EAPH) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

easton pharmaceuticals inc (EAPH) Key Developments

Easton Pharmaceuticals Closes First Wholesale Order for Skin Renou HA with BMV Medica for Mexico and Other Parts of Latin America

Easton Pharmaceuticals Inc. announces it has closed on its first wholesale order for Skin Renou HA with BMV Medica for Mexico and other parts of Latin America. The first order is for a minimum $100,000 worth of Easton's Skin Renou HA which will be distributed to various other distributors including certain clinics. The order is expected to be recurring on a regular basis and to grow as time goes by. Skin Renou will be shipped to BMV following the granting of a Mexican Import Permit, from COFEPRIS, the Mexican federal regulatory agency, which is expected within two months, since the ingredients classify Skin Renou as a cosmetic. Subsequently product shall be shipped with payment forwarded to Easton.

Easton Pharmaceuticals Inc. Announces Executive Changes

Easton Pharmaceuticals Inc. announced the appointment of Evan Karras as CEO &Director, replacing Carla Pepe, who will assume the role of Secretary and Director. Easton is also appointed Mr. Nunzio Valerie, who previously worked as a broker for 14 years as well as holding positions with several venture capital firms. Mr. Valerie will remain as President and has also assumed the position of CFO. Mr. Karras brings a wealth of knowledge and experience in the implementation of small, medium and large-scale projects on both national and international levels to Easton.

Easton Eyes Majority Stake In Xilive

Easton Pharmaceuticals Inc. (OTCPK:EAPH) anticipates working out a deal with the majority owner of "Xilive" where Easton will acquire majority control in exchange for a percentage of future royalties and shares of Easton's common stock.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
EAPH:US $0.01 USD +0.0002

EAPH Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for EAPH.
View Industry Companies
 

Industry Analysis

EAPH

Industry Average

Valuation EAPH Industry Range
Price/Earnings -- Not Meaningful
Price/Sales -- Not Meaningful
Price/Book -- Not Meaningful
Price/Cash Flow -- Not Meaningful
TEV/Sales -- Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact EASTON PHARMACEUTICALS INC, please visit www.eastonpharmaceuticalsinc.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.